Thomas M Zollner Selected Research

Thomas M Zollner Research Topics

Disease

14	Inflammation (Inflammations) 01/2019 - 03/2002
9	Endometriosis 10/2021 - 03/2012
8	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 03/2002
7	Contact Dermatitis (Eczema, Contact) 01/2012 - 11/2005
6	Neoplasms (Cancer) 12/2015 - 02/2003
5	Pain (Aches) 10/2021 - 01/2019
4	Atopic Dermatitis (Atopic Eczema) 01/2020 - 09/2007
3	Pelvic Pain 01/2021 - 07/2014
3	Skin Diseases (Skin Disease) 01/2012 - 06/2006
2	Infections 07/2014 - 02/2002
2	Atrophy 10/2011 - 09/2007
2	Wells syndrome 07/2005 - 05/2003
1	Dyspareunia 10/2021
1	Hyperalgesia 10/2021
1	Leiomyoma (Uterine Fibroids) 10/2020
1	Iron Overload 01/2020
1	Peritonitis 07/2014
1	Breast Neoplasms (Breast Cancer) 05/2012
1	Dermatitis 02/2010
1	Edema (Dropsy) 02/2010
1	Hypersensitivity (Allergy) 02/2010
1	Otitis 02/2010
1	Rheumatoid Arthritis 04/2008
1	Psoriatic Arthritis 04/2008
1	Allergic Contact Dermatitis 01/2008
1	Telangiectasis (Telangiectasia) 09/2007
1	Multiple Sclerosis 08/2006
1	Progressive Multifocal Leukoencephalopathy 08/2006
1	Experimental Melanoma 04/2004
1	Neoplasm Metastasis (Metastasis) 04/2004
1	Melanoma (Melanoma, Malignant) 04/2004

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 03/2012 - 04/2008
4	Pharmaceutical PreparationsIBA 01/2012 - 02/2003
3	AminesIBA 03/2020 - 12/2015
3	GlucocorticoidsIBA 01/2012 - 09/2007
3	DinitrofluorobenzeneIBA 01/2012 - 01/2008
2	Oxidoreductases (Dehydrogenase)IBA 03/2020 - 01/2020
2	Hormones (Hormone)IBA 01/2019 - 05/2015
2	Dinoprostone (PGE2)FDA Link 01/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 09/2012 - 05/2012
2	ChemokinesIBA 03/2012 - 09/2008
2	Prednisolone (Predate)FDA LinkGeneric 01/2012 - 04/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 04/2008
2	LigandsIBA 01/2008 - 10/2003
2	P-SelectinIBA 04/2004 - 03/2004
2	SelectinsIBA 10/2003 - 04/2002
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Purinergic P2X3 ReceptorsIBA 10/2021
1	NeuropeptidesIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Freund's AdjuvantIBA 12/2019
1	AcidsIBA 01/2019
1	ProstaglandinsIBA 01/2019
1	EnzymesIBA 01/2019
1	Prostaglandin-E SynthasesIBA 01/2019
1	Carboxylic AcidsIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 12/2015
1	rofecoxib (Vioxx)FDA Link 07/2014
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 07/2014
1	Circulating Tumor DNAIBA 09/2012
1	Cell-Free Nucleic AcidsIBA 09/2012
1	Estrogens (Estrogen)FDA Link 03/2012
1	Interleukin-12 (IL 12)IBA 01/2012
1	HaptensIBA 01/2012
1	Protein Kinases (Protein Kinase)IBA 02/2010
1	Mitogen-Activated Protein KinasesIBA 02/2010
1	Dinitrochlorobenzene (DNCB)IBA 02/2010
1	SB 203580IBA 02/2010
1	trimellitic anhydrideIBA 04/2009
1	Histone Deacetylase InhibitorsIBA 01/2009
1	trimellitic acidIBA 01/2008
1	Chemokine ReceptorsIBA 01/2008
1	AnhydridesIBA 01/2008
1	methylprednisolone aceponateIBA 09/2007
1	Triamcinolone (Aristocort)FDA Link 09/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2007
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 09/2007
1	Natalizumab (Tysabri)FDA Link 08/2006
1	Junctional Adhesion MoleculesIBA 11/2005
1	AllergensIBA 11/2005
1	Neutralizing AntibodiesIBA 11/2005
1	Furocoumarins (Furanocoumarins)IBA 05/2004
1	Ficusin (Psoralen)IBA 05/2004
1	AnticoagulantsIBA 04/2004
1	Heparin (Liquaemin)FDA LinkGeneric 04/2004
1	poly-N-acetyllactosamineIBA 10/2003
1	Antiviral Agents (Antivirals)IBA 05/2003
1	Sialyl Lewis X AntigenIBA 02/2003
1	AnthracyclinesIBA 02/2003

Therapy/Procedure

11	Therapeutics 01/2021 - 05/2003
2	Transplantation 04/2004 - 03/2002
1	Withholding Treatment 10/2021
1	Duration of Therapy 10/2011
1	Colectomy 07/2005
1	Phototherapy (Light Therapy) 05/2004
1	PUVA Therapy 05/2004